Role of nitric oxide in Parkinson's disease

Pharmacology and Therapeutics

Volumn 109, Issue 1-2, 2006, Pages 33-41

  Zhang, Li ^a   Dawson, Valina L ^a   Dawson, Ted M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Excitotoxicity; Nitric oxide; Oxidative stress; Parkinson's disease

Indexed keywords

NITRIC OXIDE;

CELL DAMAGE; CELL DEATH; CENTRAL NERVOUS SYSTEM; DNA DAMAGE; GENE MUTATION; GENETIC DISORDER; HUMAN; NEUROPROTECTION; NEUROTOXICITY; NITRATION; NITROSYLATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION;

ANIMALS; CENTRAL NERVOUS SYSTEM; DNA DAMAGE; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PARKINSON DISEASE; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 28444498107     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.05.007     Document Type: Review

References (117)

1. M. Aarts, Y. Liu, L. Liu, S. Besshoh, M. Arundine, and J.W. Gurd Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions Science 298 2002 846 850
2. W.K. Alderton, C.E. Cooper, and R.G. Knowles Nitric oxide synthases: structure, function and inhibition Biochem J 357 2001 593 615
3. C. Ayata, G. Ayata, H. Hara, R.T. Matthews, M.F. Beal, and R.J. Ferrante Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice J Neurosci 17 1997 6908 6917
4. J.S. Beckman, and W.H. Koppenol Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly Am J Physiol 271 1996 C1424 C1437
5. J.S. Beckman, M. Carson, C.D. Smith, and W.H. Koppenol ALS, SOD and peroxynitrite Nature 364 1993 584
6. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat Neurosci 3 2000 1301 1306
7. K. Bian, and F. Murad Nitric oxide (NO)-biogeneration, regulation, and relevance to human diseases Front Biosci 8 2003 d264 d278
8. D. Boehning, and S.H. Snyder Novel neural modulators Annu Rev Neurosci 26 2003 105 131
9. C. Bogdan Nitric oxide and the immune response Nat Immunol 2 2001 907 916
10. K.M. Boje Nitric oxide neurotoxicity in neurodegenerative diseases Front Biosci 9 2004 763 776
11. V. Bonifati, P. Rizzu, M.J. van Baren, O. Schaap, G.J. Breedveld, and E. Krieger Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Science 299 2003 256 259
12. D.S. Bredt, P.M. Hwang, and S.H. Snyder Localization of nitric oxide synthase indicating a neural role for nitric oxide Nature 347 1990 768 770
13. D.S. Bredt, C.E. Glatt, P.M. Hwang, M. Fotuhi, T.M. Dawson, and S.H. Snyder Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase Neuron 7 1991 615 624
14. J.E. Brenman, D.S. Chao, S.H. Gee, A.W. McGee, S.E. Craven, and D.R. Santillano Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains Cell 84 1996 757 767
15. S.E. Browne, R.J. Ferrante, and M.F. Beal Oxidative stress in Huntington's disease Brain Pathol 9 1999 147 163
16. F. Casoni, M. Basso, T. Massignan, E. Gianazza, C. Cheroni, and M. Salmona Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis J Biol Chem 280 2005 16295 16304
17. A. Castegna, V. Thongboonkerd, J.B. Klein, B. Lynn, W.R. Markesbery, and D.A. Butterfield Proteomic identification of nitrated proteins in Alzheimer's disease brain J Neurochem 85 2003 1394 1401
18. Y.B. Choi, L. Tenneti, D.A. Le, J. Ortiz, G. Bai, and H.S. Chen Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation Nat Neurosci 3 2000 15 21
19. K.S. Christopherson, B.J. Hillier, W.A. Lim, and D.S. Bredt PSD-95 assembles a ternary complex with the N-methyl-d-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain J Biol Chem 274 1999 27467 27473
20. K.K. Chung, Y. Zhang, K.L. Lim, Y. Tanaka, H. Huang, and J. Gao Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease Nat Med 7 2001 1144 1150
21. K.K. Chung, B. Thomas, X. Li, O. Pletnikova, J.C. Troncoso, and L. Marsh S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function Science 304 2004 1328 1331
22. K.L. Davis, E. Martin, I.V. Turko, and F. Murad Novel effects of nitric oxide Annu Rev Pharmacol Toxicol 41 2001 203 236
23. V.L. Dawson, and T.M. Dawson Nitric oxide in neurodegeneration Prog Brain Res 118 1998 215 229
24. T.M. Dawson, D.S. Bredt, M. Fotuhi, P.M. Hwang, and S.H. Snyder Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues Proc Natl Acad Sci U S A 88 1991 7797 7801
25. V.L. Dawson, T.M. Dawson, E.D. London, D.S. Bredt, and S.H. Snyder Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures Proc Natl Acad Sci U S A 88 1991 6368 6371
26. T.M. Dawson, V.L. Dawson, and S.H. Snyder A novel neuronal messenger molecule in brain: the free radical, nitric oxide Ann Neurol 32 1992 297 311
27. V.L. Dawson, V.M. Kizushi, P.L. Huang, S.H. Snyder, and T.M. Dawson Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice J Neurosci 16 1996 2479 2487
28. A. DelaTorre, R.A. Schroeder, and P.C. Kuo Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation Biochem Biophys Res Commun 238 1997 703 706
29. S. Dimmeler, J. Haendeler, M. Nehls, and A.M. Zeiher Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases J Exp Med 185 1997 601 607
30. J.L. Dinerman, T.M. Dawson, M.J. Schell, A. Snowman, and S.H. Snyder Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity Proc Natl Acad Sci U S A 91 1994 4214 4218
31. Y. Du, Z. Ma, S. Lin, R.C. Dodel, F. Gao, and K.R. Bales Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease Proc Natl Acad Sci U S A 98 2001 14669 14674
32. M.J. Eliasson, K. Sampei, A.S. Mandir, P.D. Hurn, R.J. Traystman, and J. Bao Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia Nat Med 3 1997 1089 1095
33. M. Endres, G. Scott, S. Namura, A.L. Salzman, P.L. Huang, and M.A. Moskowitz Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose) synthetase in a murine model of cerebral ischemia-reperfusion Neurosci Lett 248 1998 41 44
34. A.G. Estevez, N. Spear, J.A. Thompson, T.L. Cornwell, R. Radi, and L. Barbeito Nitric oxide-dependent production of cGMP supports the survival of rat embryonic motor neurons cultured with brain-derived neurotrophic factor J Neurosci 18 1998 3708 3714
35. F. Feihl, B. Waeber, and L. Liaudet Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol Ther 91 2001 179 213
36. M.W. Foster, T.J. McMahon, and J.S. Stamler S-nitrosylation in health and disease Trends Mol Med 9 2003 160 168
37. J. Garthwaite, S.L. Charles, and R. Chess-Williams Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain Nature 336 1988 385 388
38. B.I. Giasson, J.E. Duda, I.V. Murray, Q. Chen, J.M. Souza, and H.I. Hurtig Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions Science 290 2000 985 989
39. M. Gonzalez-Zulueta, L.M. Ensz, G. Mukhina, R.M. Lebovitz, R.M. Zwacka, and J.F. Engelhardt Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity J Neurosci 18 1998 2040 2055
40. P.F. Good, P. Werner, A. Hsu, C.W. Olanow, and D.P. Perl Evidence of neuronal oxidative damage in Alzheimer's disease Am J Pathol 149 1996 21 28
41. P.F. Good, A. Hsu, P. Werner, D.P. Perl, and C.W. Olanow Protein nitration in Parkinson's disease J Neuropathol Exp Neurol 57 1998 338 342
42. A.J. Gow, C.R. Farkouh, D.A. Munson, M.A. Posencheg, and H. Ischiropoulos Biological significance of nitric oxide-mediated protein modifications Am J Physiol Lung Cell Mol Physiol 287 2004 L262 L268
43. S.A. Greenacre, and H. Ischiropoulos Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction Free Radic Res 34 2001 541 581
44. J.T. Groves, and C.C. Wang Nitric oxide synthase: models and mechanisms Curr Opin Chem Biol 4 2000 687 695
45. Z. Gu, M. Kaul, B. Yan, S.J. Kridel, J. Cui, and A. Strongin S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death Science 297 2002 1186 1190
46. H.C. Ha, and S.H. Snyder Poly(ADP-ribose) polymerase-1 in the nervous system Neurobiol Dis 7 2000 225 239
47. K.A. Hanafy, J.S. Krumenacker, and F. Murad NO, nitrotyrosine, and cyclic GMP in signal transduction Med Sci Monit 7 2001 801 819
48. A. Hausladen, C.T. Privalle, T. Keng, J. DeAngelo, and J.S. Stamler Nitrosative stress: activation of the transcription factor OxyR Cell 86 1996 719 729
49. Y. He, S.Z. Imam, Z. Dong, J. Jankovic, S.F. Ali, and S.H. Appel Role of nitric oxide in rotenone-induced nigro-striatal injury J Neurochem 86 2003 1338 1345
50. R.E. Heikkila, A. Hess, and R.C. Duvoisin Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice Science 224 1984 1451 1453
51. D.T. Hess, A. Matsumoto, S.O. Kim, H.E. Marshall, and J.S. Stamler Protein S-nitrosylation: purview and parameters Nat Rev Mol Cell Biol 6 2005 150 166
52. R. Hodara, E.H. Norris, B.I. Giasson, A.J. Mishizen-Eberz, D.R. Lynch, and V.M. Lee Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation J Biol Chem 279 2004 47746 47753
53. S.J. Hong, T.M. Dawson, and V.L. Dawson Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling Trends Pharmacol Sci 25 2004 259 264
54. Z. Huang, P.L. Huang, N. Panahian, T. Dalkara, M.C. Fishman, and M.A. Moskowitz Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase Science 265 1994 1883 1885
55. S.R. Jaffrey, H. Erdjument-Bromage, C.D. Ferris, P. Tempst, and S.H. Snyder Protein S-nitrosylation: a physiological signal for neuronal nitric oxide Nat Cell Biol 3 2001 193 197
56. H.J. Kaminski, and F.H. Andrade Nitric oxide: biologic effects on muscle and role in muscle diseases Neuromuscul Disord 11 2001 517 524
57. M. Kaul, G.A. Garden, and S.A. Lipton Pathways to neuronal injury and apoptosis in HIV-associated dementia Nature 410 2001 988 994
58. J.P. Kiss, and E.S. Vizi Nitric oxide: a novel link between synaptic and nonsynaptic transmission Trends Neurosci 24 2001 211 215
59. T. Kitada, S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura, and S. Minoshima Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 1998 605 608
60. G. Kolios, V. Valatas, and S.G. Ward Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle Immunology 113 2004 427 437
61. H.C. Kornau, L.T. Schenker, M.B. Kennedy, and P.H. Seeburg Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95 Science 269 1995 1737 1740
62. H.M. Lander, J.S. Ogiste, S.F. Pearce, R. Levi, and A. Novogrodsky Nitric oxide-stimulated guanine nucleotide exchange on p21ras J Biol Chem 270 1995 7017 7020
63. A.E. Lang, and A.M. Lozano Parkinson's disease. First of two parts N Engl J Med 339 1998 1044 1053
64. A.E. Lang, and A.M. Lozano Parkinson's disease. Second of two parts N Engl J Med 339 1998 1130 1143
65. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980
66. J.W. Langston, L.S. Forno, J. Tetrud, A.G. Reeves, J.A. Kaplan, and D. Karluk Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure Ann Neurol 46 1999 598 605
67. A. Law, S. Gauthier, and R. Quirion Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type Brain Res Brain Res Rev 35 2001 73 96
68. G.T. Liberatore, V. Jackson-Lewis, S. Vukosavic, A.S. Mandir, M. Vila, and W.G. McAuliffe Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease Nat Med 5 1999 1403 1409
69. Lipton, S. A. (2001). Physiology. Nitric oxide and respiration Nature 413, 118-9, 121.
70. S.A. Lipton, Y.B. Choi, Z.H. Pan, S.Z. Lei, H.S. Chen, and N.J. Sucher A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds Nature 364 1993 626 632
71. L. Liu, A. Hausladen, M. Zeng, L. Que, J. Heitman, and J.S. Stamler A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans Nature 410 2001 490 494
72. L. Liu, Y. Yan, M. Zeng, J. Zhang, M.A. Hanes, and G. Ahearn Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock Cell 116 2004 617 628
73. E.H. Lo, T. Dalkara, and M.A. Moskowitz Mechanisms, challenges and opportunities in stroke Nat Rev Neurosci 4 2003 399 415
74. A.S. Mandir, S. Przedborski, V. Jackson-Lewis, Z.Q. Wang, C.M. Simbulan-Rosenthal, and M.E. Smulson Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism Proc Natl Acad Sci U S A 96 1999 5774 5779
75. A.S. Mandir, M.F. Poitras, A.R. Berliner, W.J. Herring, D.B. Guastella, and A. Feldman NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase J Neurosci 20 2000 8005 8011
76. J.B. Mannick, A. Hausladen, L. Liu, D.T. Hess, M. Zeng, and Q.X. Miao Fas-induced caspase denitrosylation Science 284 1999 651 654
77. J.B. Mannick, C. Schonhoff, N. Papeta, P. Ghafourifar, M. Szibor, and K. Fang S-nitrosylation of mitochondrial caspases J Cell Biol 154 2001 1111 1116
78. H.E. Marshall, and J.S. Stamler Inhibition of NF-kappa B by S-nitrosylation Biochemistry 40 2001 1688 1693
79. J.R. Matthews, C.H. Botting, M. Panico, H.R. Morris, and R.T. Hay Inhibition of NF-kappaB DNA binding by nitric oxide Nucleic Acids Res 24 1996 2236 2242
80. G. Melino, F. Bernassola, R.A. Knight, M.T. Corasaniti, G. Nistico, and A. Finazzi-Agro S-nitrosylation regulates apoptosis Nature 388 1997 432 433
81. D.J. Moore, A.B. West, V.L. Dawson, and T.M. Dawson Molecular pathophysiology of Parkinson's disease Annu Rev Neurosci 28 2004 57 87
82. E.H. Norris, B.I. Giasson, H. Ischiropoulos, and V.M. Lee Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications J Biol Chem 278 2003 27230 27240
83. S.A. Oliveira, W.K. Scott, E.R. Martin, M.A. Nance, R.L. Watts, and J.P. Hubble Parkin mutations and susceptibility alleles in late-onset Parkinson's disease Ann Neurol 53 2003 624 629
84. C. Paisan-Ruiz, S. Jain, E.W. Evans, W.P. Gilks, J. Simon, and M. van der Brug Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease Neuron 44 2004 595 600
85. H.S. Park, J.W. Yu, J.H. Cho, M.S. Kim, S.H. Huh, and K. Ryoo Inhibition of apoptosis signal-regulating kinase 1 by nitric oxide through a thiol redox mechanism J Biol Chem 279 2004 7584 7590
86. E. Paxinou, Q. Chen, M. Weisse, B.I. Giasson, E.H. Norris, and S.M. Rueter Induction of alpha-synuclein aggregation by intracellular nitrative insult J Neurosci 21 2001 8053 8061
87. A.A. Pieper, A. Verma, J. Zhang, and S.H. Snyder Poly (ADP-ribose) polymerase, nitric oxide and cell death Trends Pharmacol Sci 20 1999 171 181
88. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, and A. Dutra Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
89. H. Prast, and A. Philippu Nitric oxide as modulator of neuronal function Prog Neurobiol 64 2001 51 68
90. S. Przedborski, V. Jackson-Lewis, R. Yokoyama, T. Shibata, V.L. Dawson, and T.M. Dawson Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity Proc Natl Acad Sci U S A 93 1996 4565 4571
91. S. Przedborski, Q. Chen, M. Vila, B.I. Giasson, R. Djaldatti, and S. Vukosavic Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease J Neurochem 76 2001 637 640
92. N.L. Reynaert, K. Ckless, S.H. Korn, N. Vos, A.S. Guala, and E.F. Wouters Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation Proc Natl Acad Sci U S A 101 2004 8945 8950
93. A.F. Samdani, T.M. Dawson, and V.L. Dawson Nitric oxide synthase in models of focal ischemia Stroke 28 1997 1283 1288
94. R. Sattler, Z. Xiong, W.Y. Lu, M. Hafner, J.F. MacDonald, and M. Tymianski Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein Science 284 1999 1845 1848
95. K. Shibuki, and D. Okada Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum Nature 349 1991 326 328
96. A.B. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague, and J. Kachergus Alpha-synuclein locus triplication causes Parkinson's disease Science 302 2003 841
97. K.J. Smith, and H. Lassmann The role of nitric oxide in multiple sclerosis Lancet Neurol 1 2002 232 241
98. M.A. Smith, P.L. Richey Harris, L.M. Sayre, J.S. Beckman, and G. Perry Widespread peroxynitrite-mediated damage in Alzheimer's disease J Neurosci 17 1997 2653 2657
99. J.S. Stamler, and G. Meissner Physiology of nitric oxide in skeletal muscle Physiol Rev 81 2001 209 237
100. J.S. Stamler, D.I. Simon, J.A. Osborne, M.E. Mullins, O. Jaraki, and T. Michel S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds Proc Natl Acad Sci U S A 89 1992 444 448
101. J.S. Stamler, S. Lamas, and F.C. Fang Nitrosylation. The prototypic redox-based signaling mechanism Cell 106 2001 675 683
102. H. Takahashi, E. Ohama, S. Suzuki, Y. Horikawa, A. Ishikawa, and T. Morita Familial juvenile parkinsonism: clinical and pathologic study in a family Neurology 44 1994 437 441
103. L.L. Thomsen, and J. Olesen Nitric oxide in primary headaches Curr Opin Neurol 14 2001 315 321
104. F. Torreilles, S. Salman-Tabcheh, M. Guerin, and J. Torreilles Neurodegenerative disorders: the role of peroxynitrite Brain Res Brain Res Rev 30 1999 153 163
105. E.M. Valente, P.M. Abou-Sleiman, V. Caputo, M.M. Muqit, K. Harvey, and S. Gispert Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 2004 1158 1160
106. R. Von Coelln, B. Thomas, J.M. Savitt, K.L. Lim, M. Sasaki, and E.J. Hess Loss of locus coeruleus neurons and reduced startle in parkin null mice Proc Natl Acad Sci U S A 101 2004 10744 10749
107. H. Wang, S.W. Yu, D.W. Koh, J. Lew, C. Coombs, and W. Bowers Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death J Neurosci 24 2004 10963 10973
108. A. West, M. Periquet, S. Lincoln, C.B. Lucking, D. Nicholl, and V. Bonifati Complex relationship between Parkin mutations and Parkinson disease Am J Med Genet 114 2002 584 591
109. D.C. Wu, V. Jackson-Lewis, M. Vila, K. Tieu, P. Teismann, and C. Vadseth Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine mouse model of Parkinson disease J Neurosci 22 2002 1763 1771
110. G. Yamin, C.B. Glaser, V.N. Uversky, and A.L. Fink Certain metals trigger fibrillation of methionine-oxidized alpha-synuclein J Biol Chem 278 2003 27630 27635
111. D. Yao, Z. Gu, T. Nakamura, Z.Q. Shi, Y. Ma, and B. Gaston Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity Proc Natl Acad Sci U S A 101 2004 10810 10814
112. S.W. Yu, H. Wang, M.F. Poitras, C. Coombs, W.J. Bowers, and H.J. Federoff Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor Science 297 2002 259 263
113. S.W. Yu, H. Wang, T.M. Dawson, and V.L. Dawson Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity Neurobiol Dis 14 2003 303 317
114. H.Y. Yun, M. Gonzalez-Zulueta, V.L. Dawson, and T.M. Dawson Nitric oxide mediates N-methyl-d-aspartate receptor-induced activation of p21ras Proc Natl Acad Sci U S A 95 1998 5773 5778
115. J. Zhang, V.L. Dawson, T.M. Dawson, and S.H. Snyder Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity Science 263 1994 687 689
116. Y. Zhang, V.L. Dawson, and T.M. Dawson Oxidative stress and genetics in the pathogenesis of Parkinson's disease Neurobiol Dis 7 2000 240 250
117. A. Zimprich, S. Biskup, P. Leitner, P. Lichtner, M. Farrer, and S. Lincoln Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 44 2004 601 607